A CASE OF TYROSINE KINASE INHIBITOR (DASATINIB)-INDUCED ANGIOEDEMA

被引：0
|
作者：
Peterson, J.
Toro, J.
Welch, N.
Lalmuanpuii, J.
Tarbox, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
M045
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [31] Tyrosine Kinase Inhibitor Induced Proteinuria - A Review
    Gayathri, J. S.
    Krishna, S. Swathi
    Rakesh, M. P.
    DRUG RESEARCH, 2025, 75 (01) : 5 - 11
  • [32] Tyrosine Kinase Inhibitor-induced Macrocytosis
    Schallier, D.
    Trullemans, F.
    Fontaine, C.
    Decoster, L.
    De Greve, J.
    ANTICANCER RESEARCH, 2009, 29 (12) : 5225 - 5228
  • [33] The Tyrosine Kinase Inhibitor Dasatinib Dysregulates Bone Remodeling Through Inhibition of Osteoclasts In Vivo
    Vandyke, Kate
    Dewar, Andrea L.
    Diamond, Peter
    Fitter, Stephen
    Schultz, Christopher G.
    Sims, Natalie A.
    Zannettino, Andrew C. W.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (08) : 1759 - 1770
  • [34] PERICARDIAL EFFUSION INDUCED BY TYROSINE KINASE INHIBITOR RELATED HYPOTHYROIDISM PERICARDIAL EFFUSION INDUCED BY TYROSINE KINASE INHIBITOR RELATED HYPOTHYROIDISM
    Sut, D.
    Antonutti, M.
    Tioni, C.
    Pagura, L.
    Collini, V.
    De Biasio, M.
    Sinagra, G.
    Proclemer, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E91 - E91
  • [35] Interaction of the chemotherapeutic agent oxaliplatin and the tyrosine kinase inhibitor dasatinib with the organic cation transporter 2
    Eltayeb, Sara
    Dressler, Julia M.
    Schlatt, Lukas
    Pernecker, Moritz
    Neugebauer, Ute
    Karst, Uwe
    Ciarimboli, Giuliano
    ARCHIVES OF TOXICOLOGY, 2024, 98 (07) : 2131 - 2142
  • [36] Stable Fatty Acid Solvates of Dasatinib, a Tyrosine Kinase Inhibitor: Prediction, Process, and Physicochemical Properties
    Saladi, Venkata Narasayya
    Kammari, Bal Raju
    Maruthapillai, Arthanareeswari
    Mahapatra, Sudarshan
    Chennuru, Ramanaiah
    Sajja, Eswaraiah
    Rajan, Srinivasan Thirumalai
    Mathad, Vijayavitthal T.
    ACS OMEGA, 2022, 7 (08): : 7032 - 7044
  • [37] Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
    Mustjoki, S.
    Ekblom, M.
    Arstila, T. P.
    Dybedal, I.
    Epling-Burnette, P. K.
    Guilhot, F.
    Hjorth-Hansen, H.
    Hoglund, M.
    Kovanen, P.
    Laurinolli, T.
    Liesveld, J.
    Paquette, R.
    Pinilla-Ibarz, J.
    Rauhala, A.
    Shah, N.
    Simonsson, B.
    Sinisalo, M.
    Steegmann, J. L.
    Stenke, L.
    Porkka, K.
    LEUKEMIA, 2009, 23 (08) : 1398 - 1405
  • [38] Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy
    Mustjoki, Satu
    Ekblom, Marja
    Arstila, T. Petteri
    Dybedal, Ingunn
    Epling-Burnette, P. K.
    Garzon, Felix
    Gedde-Dahl, Tobias
    Hernesniemi, Sari
    Hjorth-Hansen, Henrik
    Hoglund, Martin
    Juvonen, Vesa
    Kairisto, Veli
    Kovanen, Panu
    Kreutzman, Anna
    Laurinolli, Tuisku
    Liesveld, Jane
    Paquette, Ronald
    Pinilla, Javier
    Rauhala, Auvo
    Shah, Neil
    Simonsson, Bengt
    Sinisalo, Marjatta
    Luis Steegmann, Juan
    Stenke, Leif
    Vakkila, Jukka
    Porkka, Kimmo
    BLOOD, 2008, 112 (11) : 215 - 215
  • [39] Effect of the SRC tyrosine kinase inhibitor dasatinib in combination with erlotinib and in cells with acquired resistance to erlotinib
    Haura, E.
    Gao, J.
    Li, J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 182 - 182
  • [40] Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
    S Mustjoki
    M Ekblom
    T P Arstila
    I Dybedal
    P K Epling-Burnette
    F Guilhot
    H Hjorth-Hansen
    M Höglund
    P Kovanen
    T Laurinolli
    J Liesveld
    R Paquette
    J Pinilla-Ibarz
    A Rauhala
    N Shah
    B Simonsson
    M Sinisalo
    J L Steegmann
    L Stenke
    K Porkka
    Leukemia, 2009, 23 : 1398 - 1405
12345